DRUG · Mapped RxNorm record
Lixisenatide
Normalized identity: lixisenatideView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain
NCT02745470
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetes Mellitusverified · MONDO: diabetes mellitus
Interventions
LixisenatideDRUG · verified · RxNorm: lixisenatide
PlaceboOTHER
Sponsors & collaborators
Seoul National University Hospitallead sponsor
Seoul National Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02745470 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.